Bind Therapeutics Wins OK Of $40M Ch. 11 Sale to Pfizer
Cancer drug developer Bind Therapeutics Inc. secured Delaware bankruptcy court approval Wednesday for a $40 million sale of most assets to Pfizer Inc., after emerging from a Delaware Chapter 11 auction...To view the full article, register now.
Already a subscriber? Click here to view full article